US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Brian Abrahams

Recent news which mentions Brian Abrahams

Regeneron Pharma's Pipeline Makes This Analyst Turn Bullish
Tickers REGN VTRS
Tags Analyst Color General VTRS
From Benzinga
Why Neumora Therapeutics Analysts Are Bullish About Major Depressive Disorder Drug
Tickers NMRA
Tags Myles Minter Benzinga Market News
From Benzinga
Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target
Tickers INCY
Tags Expert Ideas Downgrades RBC Capital Markets
From Benzinga
7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%
Tickers BIIB
Tags Market News Morgan Stanley Geoff Meacham
From Benzinga
Why This Analyst Sees Roughly 20% Upside In This Large-Cap Biopharma
Tickers BIIB
Tags Analyst Ratings General Analyst Color
From Benzinga